| Members |
targetComponentId |
| pT2 category |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Organ confined (prostate) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor extends to the soft tissues (nasopharynx) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades duodenal wall (ampulla of Vater) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades muscularis (renal pelvis and ureter) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades muscularis propria (appendix) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades muscularis propria (colon/rectum) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades muscularis propria (esophagus) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades muscularis propria (small intestine) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades muscularis propria or subserosa (stomach) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (breast) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 8 cm in greatest dimension (bone) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) |
American Joint Committee on Cancer pT2 (qualifier value) |
| pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a category |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor invades muscularis propria (stomach) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2a: Unilateral, one-half of one lobe or less (prostate) |
American Joint Committee on Cancer pT2a (qualifier value) |
| pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
pT2b |
| pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) |
pT2b |
| pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) |
pT2b |
| pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
pT2b |
| pT2b category |
pT2b |
| pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) |
pT2b |
| pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
pT2b |
| pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) |
pT2b |
| pT2b: Tumor invades choroid focally (retinoblastoma) |
pT2b |
| pT2b: Tumor invades deep muscle (outer half) (urinary bladder) |
pT2b |
| pT2b: Tumor invades subserosa (stomach) |
pT2b |
| pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT2b |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
pT2b |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) |
pT2b |
| pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) |
pT2b |
| pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c category |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c: Bilateral disease (prostate) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
American Joint Committee on Cancer pT2c (qualifier value) |
| pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) |
pT3 |
| pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) |
pT3 |
| pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) |
pT3 |
| pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) |
pT3 |
| pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) |
pT3 |
| pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) |
pT3 |
| pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) |
pT3 |
| pT3 category |
pT3 |
| pT3: Discontinuous tumors in the primary bone site (bone) |
pT3 |
| pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) |
pT3 |
| pT3: Extraprostatic extension (prostate) |
pT3 |
| pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) |
pT3 |
| pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) |
pT3 |
| pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) |
pT3 |
| pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) |
pT3 |
| pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) |
pT3 |
| pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) |
pT3 |
| pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) |
pT3 |
| pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) |
pT3 |
| pT3: Tumor invades adventitia (esophagus) |
pT3 |
| pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) |
pT3 |
| pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) |
pT3 |
| pT3: Tumor invades beyond muscularis into periureteric fat (ureter) |
pT3 |
| pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) |
pT3 |
FHIR